180 Life Sciences Corp (NASDAQ:ATNF) currently has a daily average trading volume of 2.01M but it saw 16118701 shares traded in last market. With a market cap of 8.89M USD, the company’s current market price of $2.90 came rising about 55.08 while comparing to the previous closing price of $1.87. In past 52 weeks, the stock remained buoying in the range of price level as high as $17.75 and as low as $1.16. In the recent trading on the day, stock has struck highest price mark of $2.13 while lowest mark touched by it was $3.19.
Taking a look at 20-day trading activity of 180 Life Sciences Corp (ATNF) gives us an average price of $2.1000, while its current price level is -83.66% below from 52-week high level whereas it is 150.00% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.9000 while that of 200 days or SMA-200 reads an average of $2.2000. A closer look into the stock’s movement over the week reveals that its volatility is standing at 18.70% during that period while stretching the period over a month that decreases to 11.99%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 60.89 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Maxim Group which initiated the stock as “Buy” in its note to investors issued on September 15, 2021, recommending a price target of $11 for it.
Over the week, ATNF’s stock price is moving 47.80% up while it is 19.56% when we observe its performance for the past one month. Year-to-date it is -33.69% down and over the past year, the stock is showing a downside performance of -23.92%.
The company is expected to be releasing its next quarterly report in January, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, 180 Life Sciences Corp’s total number of outstanding shares is 1.03M. Company’s return on investment (ROI) stands at -83.37% and return on equity (ROE) at -174.19%. Stock has a price to book (P/B) ratio of 0.80. Its return on asset (ROA) is -40.47% on average.
